Clinical trial
A Study of the Clinical Benefit of Tobramycin Inhalation Solution
NCT06106789 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of the Clinical Benefit of Tobramycin Inhalation Solution
- Lead sponsor
- Qianfoshan Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 1, 2023
- Completion date
- October 30, 2024
- Enrollment
- 1,600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bronchiectasis, cystic fibrosis, lung infection